240 related articles for article (PubMed ID: 25357001)
1. Analytical procedure validation and the quality by design paradigm.
Rozet E; Lebrun P; Michiels JF; Sondag P; Scherder T; Boulanger B
J Biopharm Stat; 2015; 25(2):260-8. PubMed ID: 25357001
[TBL] [Abstract][Full Text] [Related]
2. A quality by design approach for longitudinal quality attributes.
Lebrun P; Giacoletti K; Scherder T; Rozet E; Boulanger B
J Biopharm Stat; 2015; 25(2):247-59. PubMed ID: 25360720
[TBL] [Abstract][Full Text] [Related]
3. Guest editors' note: special issue on recent developments in statistical approaches for chemistry and manufacturing control (CMC) and quality-by-design(QbD).
Tsong Y; Yang H
J Biopharm Stat; 2015; 25(2):233. PubMed ID: 25437635
[No Abstract] [Full Text] [Related]
4. Testing assay linearity over a pre-specified range.
Yang H; Novick SJ; LeBlond D
J Biopharm Stat; 2015; 25(2):339-50. PubMed ID: 25356663
[TBL] [Abstract][Full Text] [Related]
5. Using tolerance intervals for assessment of pharmaceutical quality.
Dong X; Tsong Y; Shen M; Zhong J
J Biopharm Stat; 2015; 25(2):317-27. PubMed ID: 25356617
[TBL] [Abstract][Full Text] [Related]
6. Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
Novick S; Shen Y; Yang H; Peterson J; LeBlond D; Altan S
J Biopharm Stat; 2015; 25(2):351-71. PubMed ID: 25357203
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
Tsong Y; Dong X; Shen M; Lostritto RT
J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
[TBL] [Abstract][Full Text] [Related]
8. Statistical considerations in setting product specifications.
Dong X; Tsong Y; Shen M
J Biopharm Stat; 2015; 25(2):280-94. PubMed ID: 25358110
[TBL] [Abstract][Full Text] [Related]
9. Non-normal random effects models for immunogenicity assay cut point determination.
Zhang J; Yu B; Zhang L; Roskos L; Richman L; Yang H
J Biopharm Stat; 2015; 25(2):295-306. PubMed ID: 25356500
[TBL] [Abstract][Full Text] [Related]
10. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
Fan Z; Zhang L
J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
[TBL] [Abstract][Full Text] [Related]
11. A statistical approach to determining criticality of residual host cell DNA.
Yang H; Wei Z; Schenerman M
J Biopharm Stat; 2015; 25(2):234-46. PubMed ID: 25358029
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian design space for analytical methods based on multivariate models and predictions.
Lebrun P; Boulanger B; Debrus B; Lambert P; Hubert P
J Biopharm Stat; 2013; 23(6):1330-51. PubMed ID: 24138435
[TBL] [Abstract][Full Text] [Related]
13. Statistical evaluation of several methods for cut-point determination of immunogenicity screening assay.
Shen M; Dong X; Tsong Y
J Biopharm Stat; 2015; 25(2):269-79. PubMed ID: 25356783
[TBL] [Abstract][Full Text] [Related]
14. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
[TBL] [Abstract][Full Text] [Related]
15. Validation of analytical methods involved in dissolution assays: acceptance limits and decision methodologies.
Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
Anal Chim Acta; 2012 Nov; 751():44-51. PubMed ID: 23084050
[TBL] [Abstract][Full Text] [Related]
16. Application of quality by design to the development of analytical separation methods.
Orlandini S; Pinzauti S; Furlanetto S
Anal Bioanal Chem; 2013 Jan; 405(2-3):443-50. PubMed ID: 22941176
[TBL] [Abstract][Full Text] [Related]
17. A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by design.
Martin-Moe S; Lim FJ; Wong RL; Sreedhara A; Sundaram J; Sane SU
J Pharm Sci; 2011 Aug; 100(8):3031-3043. PubMed ID: 21425164
[TBL] [Abstract][Full Text] [Related]
18. Design space approach in the optimization of the spray-drying process.
Lebrun P; Krier F; Mantanus J; Grohganz H; Yang M; Rozet E; Boulanger B; Evrard B; Rantanen J; Hubert P
Eur J Pharm Biopharm; 2012 Jan; 80(1):226-34. PubMed ID: 21983606
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the recovery spread in analytical development and routine quality control--based on the ICH quality guideline Q2B.
Schepers U; El Deeb S; Ermer J; Wätzig H
J Pharm Biomed Anal; 2007 Jan; 43(2):708-10. PubMed ID: 16904281
[TBL] [Abstract][Full Text] [Related]
20. Quality by design compliant analytical method validation.
Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
Anal Chem; 2012 Jan; 84(1):106-12. PubMed ID: 22107128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
